K. Lance Gould, MD

Biography

Lance Gould, MD, holds the Distinguished University Chair in Cardiovascular Medicine at The University of Texas Health Science Center at Houston (UTHealth Houston) based on 48 years of experience in clinical cardiac practice and research. He pioneered all the current concepts and imaging tests, quantitative angiograms and coronary pressure measurements for defining severity of coronary artery disease, now used worldwide electively for coronary artery disease.

Accordingly, he leads the world on imaging coronary blood flow using technology he pioneered called positron emission tomography (PET) as the basis for predicting high future risk of heart attack or death in individuals, and whether stents or bypass surgery may reduce this risk; or whether intense healthy living and medical treatment may stop or reverse coronary artery disease.

His leading technology developments and 48 years of clinical experience bring unique clinical insight, judgment and professional care for objective, optimal and personalized treatment opinions for individual patients, especially for those with angiogram, stents or bypass surgery recommendations including the world leading definitive imaging and experience that he provides.

Dr. Gould is the medical and executive director of the Weatherhead PET Imaging Center for Preventing and Reversing Atherosclerosis at UTHealth Houston, serving patients and physicians in the United States and around the world.

He won the International George von Hevesy Prize for Research in 1978, the AHA George E. Brown Memorial Lecturer in 1990, the American College of Cardiology Simon Dack Award for Outstanding Scholarship in 2011, the Hal Anger Memorial Honorary Plenary Lecturer of the Society of Nuclear Medicine in 2017 and the American College of Cardiology Distinguished Scientist Award for Translational Research in 2018.

Click here to learn more about the Weather PET Imaging Center or see Dr. Gould’s summarized original conceptual papers.

Board Certifications

• National Board of Medical Examiners
• Board Eligible in Cardiovascular Disease